These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11023538)

  • 21. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia.
    Sirma S; Agaoglu L; Yildiz I; Cayli D; Horgusluoglu E; Anak S; Yuksel L; Unuvar A; Celkan T; Apak H; Karakas Z; Devecioglu O; Ozbek U
    Pediatr Blood Cancer; 2004 Oct; 43(5):568-70. PubMed ID: 15382274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
    Yadav U; Kumar P; Rai V
    Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Analysis of NADPH Quinone Reductase 1 (NQO1) Polymorphism in Polish Patients with Colorectal Cancer.
    Gorący J; Bogacz A; Uzar I; Wolek M; Łochyńska M; Ziętek P; Czerny B; Cymbaluk-Płoska A; Modliborski P; Kamiński A
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of the NAD(P)H: quinone oxidoreductase C609T polymorphism and the risk of cervical cancer in Japanese subjects.
    Niwa Y; Hirose K; Nakanishi T; Nawa A; Kuzuya K; Tajima K; Hamajima N
    Gynecol Oncol; 2005 Feb; 96(2):423-9. PubMed ID: 15661231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis of the association between NQO1 C609T variation and acute myeloid leukemia risk.
    Li C; Liu Y; Wei S; Zhou Y
    Pediatr Blood Cancer; 2014 May; 61(5):771-7. PubMed ID: 24474393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke.
    Shyu HY; Fong CS; Fu YP; Shieh JC; Yin JH; Chang CY; Wang HW; Cheng CW
    Clin Chim Acta; 2010 Jun; 411(11-12):840-5. PubMed ID: 20193673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
    Larson RA; Wang Y; Banerjee M; Wiemels J; Hartford C; Le Beau MM; Smith MT
    Blood; 1999 Jul; 94(2):803-7. PubMed ID: 10397748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of fruit and vegetable consumption and genetic variation on NAD(P)H:quinone oxidoreductase (NQO1) phenotype in an endoscopy-based population.
    Tijhuis MJ; Boerboom AM; Visker MH; Op den Camp L; Nagengast FM; Tan AC; Rietjens IM; Kok FJ; Aarts JM; Kampman E
    Nutr Cancer; 2008; 60(2):204-15. PubMed ID: 18444152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
    Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
    Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of NAD(P)H:quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a multivariate model to rank the relative importance of this polymorphism and those at other relevant loci.
    Clairmont A; Sies H; Ramachandran S; Lear JT; Smith AG; Bowers B; Jones PW; Fryer AA; Strange RC
    Carcinogenesis; 1999 Jul; 20(7):1235-40. PubMed ID: 10383895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
    Lanciotti M; Dufour C; Corral L; Di Michele P; Pigullo S; De Rossi G; Basso G; Leszl A; Luciani M; Lo Nigro L; Micalizzi C; Valsecchi MG; Biondi A; Haupt R
    Leukemia; 2005 Feb; 19(2):214-6. PubMed ID: 15618957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectrum of K ras mutations in Pakistani colorectal cancer patients.
    Murtaza BN; Bibi A; Rashid MU; Khan YI; Chaudri MS; Shakoori AR
    Braz J Med Biol Res; 2014 Jan; 47(1):35-41. PubMed ID: 24519090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotype-phenotype relationships in studies of a polymorphism in NAD(P)H:quinone oxidoreductase 1.
    Siegel D; McGuinness SM; Winski SL; Ross D
    Pharmacogenetics; 1999 Feb; 9(1):113-21. PubMed ID: 10208650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No association between Helicobacter pylori seropositivity and ornithine decarboxylase (ODC) A317G polymorphism, and no modification by NAD(P)H:qinone oxidoreductase 1 (NQO1) C609T.
    Goto Y; Nishio K; Ishida Y; Kawai S; Osafune T; Naito M; Katsuda N; Hamajima N
    Nagoya J Med Sci; 2007 Jan; 69(1-2):17-22. PubMed ID: 17378176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of NAD(P)H: quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: A potential biomarker of early damage in the pancreas.
    Lyn-Cook BD; Yan-Sanders Y; Moore S; Taylor S; Word B; Hammons GJ
    Cell Biol Toxicol; 2006 Mar; 22(2):73-80. PubMed ID: 16532285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NAD(P)H: quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 polymorphisms in papillary thyroid microcarcinoma: correlation with phenotype.
    Lee J; Kim KS; Lee MH; Kim YS; Lee MH; Lee SE; Kim YK; Ryu MJ; Kim SJ; Choi MJ; Jo YS
    Yonsei Med J; 2013 Sep; 54(5):1158-67. PubMed ID: 23918565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NQO1 C609T polymorphism and risk of lung cancer: a meta-analysis.
    Liu Y; Zhang D
    Asian Pac J Cancer Prev; 2011; 12(11):3091-5. PubMed ID: 22393995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Gong M; Yi Q; Wang W
    Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population.
    Lewis SJ; Cherry NM; Niven RM; Barber PV; Povey AC
    Lung Cancer; 2001 Nov; 34(2):177-83. PubMed ID: 11679176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.